Hemorrhagic transformation and stroke recurrence in children with cardiac disease receiving antithrombotic therapy for secondary stroke prevention.
Elizabeth PulcineMike SeedLeonardo Rodrigues BrandãoMahmoud SlimSunitha PalasamudramManohar ShroffMahendranath MoharirGabrielle deVeberNomazulu DlaminiPublished in: Journal of thrombosis and haemostasis : JTH (2021)
In spite of the 24% hemorrhagic transformation rate, antithrombotic therapy has a positive risk-balance in certain cardioembolic stroke subgroups, particularly in those with single-ventricle physiology, when accounting for stroke volume.